Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yosef Sarne

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
The American Journal of Drug and Alcohol Abuse|March 14, 2019
Beneficial and deleterious effects of cannabinoids in the brain: the case of ultra-low dose THCYosef Sarne
Brain Research|July 18, 2003
Multiple mechanisms of CB1 cannabinoid receptors regulationOra Keren, Yosef Sarne
Current Drug Targets. CNS and Neurological Disorders|December 27, 2005
Cannabinoids: between neuroprotection and neurotoxicityYosef Sarne, Raphael Mechoulam
Brain Research. Molecular Brain Research|February 20, 2003
The mu opioid agonist DAMGO stimulates cAMP production in SK-N-SH cells through a PLC-PKC-Ca++ pathwayVardit Rubovitch, Mikhal Gafni, Yosef Sarne
Brain Research|December 31, 2002
Long-term interactions between opioid and cannabinoid agonists at the cellular level: cross-desensitization and downregulationMa'anit Shapira, Mikhal Gafni, Yosef Sarne
Brain Research. Molecular Brain Research|January 27, 2004
The involvement of VEGF receptors and MAPK in the cannabinoid potentiation of Ca2+ flux into N18TG2 neuroblastoma cellsVardit Rubovitch, Mikhal Gafni, Yosef Sarne
Brain Research. Molecular Brain Research|May 15, 2002
The cannabinoid agonist DALN positively modulates L-type voltage-dependent calcium-channels in N18TG2 neuroblastoma cellsVardit Rubovitch, Mikhal Gafni, Yosef Sarne
Addiction Biology|June 4, 2009
Is withdrawal hyperalgesia in morphine-dependent mice a direct effect of a low concentration of the residual drug?Vardit Rubovitch, Chaim G Pick, Yosef Sarne
Journal of Neuroscience Research|July 22, 2014
Ultralow doses of cannabinoid drugs protect the mouse brain from inflammation-induced cognitive damageMiriam Fishbein-Kaminietsky, Mikhal Gafni, Yosef Sarne
Pharmacology, Biochemistry, and Behavior|September 25, 2007
Long-term cognitive deficits induced by a single, extremely low dose of tetrahydrocannabinol (THC): behavioral, pharmacological and biochemical studies in miceRoey Senn, Ora Keren, Aya Hefetz, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
The American Journal of Drug and Alcohol Abuse|March 14, 2019
Beneficial and deleterious effects of cannabinoids in the brain: the case of ultra-low dose THCYosef Sarne
Brain Research|July 18, 2003
Multiple mechanisms of CB1 cannabinoid receptors regulationOra Keren, Yosef Sarne
Current Drug Targets. CNS and Neurological Disorders|December 27, 2005
Cannabinoids: between neuroprotection and neurotoxicityYosef Sarne, Raphael Mechoulam
Brain Research. Molecular Brain Research|February 20, 2003
The mu opioid agonist DAMGO stimulates cAMP production in SK-N-SH cells through a PLC-PKC-Ca++ pathwayVardit Rubovitch, Mikhal Gafni, Yosef Sarne
Brain Research|December 31, 2002
Long-term interactions between opioid and cannabinoid agonists at the cellular level: cross-desensitization and downregulationMa'anit Shapira, Mikhal Gafni, Yosef Sarne
Brain Research. Molecular Brain Research|January 27, 2004
The involvement of VEGF receptors and MAPK in the cannabinoid potentiation of Ca2+ flux into N18TG2 neuroblastoma cellsVardit Rubovitch, Mikhal Gafni, Yosef Sarne
Brain Research. Molecular Brain Research|May 15, 2002
The cannabinoid agonist DALN positively modulates L-type voltage-dependent calcium-channels in N18TG2 neuroblastoma cellsVardit Rubovitch, Mikhal Gafni, Yosef Sarne
Addiction Biology|June 4, 2009
Is withdrawal hyperalgesia in morphine-dependent mice a direct effect of a low concentration of the residual drug?Vardit Rubovitch, Chaim G Pick, Yosef Sarne
Journal of Neuroscience Research|July 22, 2014
Ultralow doses of cannabinoid drugs protect the mouse brain from inflammation-induced cognitive damageMiriam Fishbein-Kaminietsky, Mikhal Gafni, Yosef Sarne
Pharmacology, Biochemistry, and Behavior|September 25, 2007
Long-term cognitive deficits induced by a single, extremely low dose of tetrahydrocannabinol (THC): behavioral, pharmacological and biochemical studies in miceRoey Senn, Ora Keren, Aya Hefetz, et al.
Pageof 3